PDF电子书：LIPOPROTEINS – ROLE IN HEALTH AND DISEASES （2012）

xyklmu

. J" ~" W4 H4 f3 F5 Y2 z- q
. @, n4 Y( Q4 A2 w[hide][/hide]5 Z8 n8 ^# H, _; v+ B
LIPOPROTEINS – ROLE IN HEALTH AND DISEASES
' r: r/ e8 y/ DEdited by Saša Frank and Gerhard Kostner0 a. T1 l7 {: p/ U; M0 A. `
2 g. F& G3 u6 A& }; j
共28章 774页
; a' C. T7 E! n3 @0 y0 d! ?6 h5 @9 v2 R; M4 Z- _
+ Q0 X/ z8 j8 D+ V
Contents
3 f" s* S0 v$ G1 \$ QPreface XI
+ [' I4 _7 s& c2 q% z8 HSection 1 Lipoprotein Structure and Assembly 1+ \: W4 L" O' }( ~* P* H& R
Chapter 1 Lipoprotein Structure and Dynamics: Low Density Lipoprotein Viewed as a Highly Dynamic and Flexible Nanoparticle 3
  c. E! ~/ |3 ]+ F+ {Ruth Prassl and Peter Laggner
( S! I+ J" y6 I; f5 F# g; Z% SChapter 2 New Insights into the Assembly and Metabolism of ApoB-Containing Lipoproteins
6 W% `% q5 \( q6 k6 }% wfrom in vivo Kinetic Studies: Results on Healthy Subjects and Patients with Chronic Kidney Disease 218 f* ^, x2 p! Q3 D; j
Benjamin Dieplinger and Hans Dieplinger5 s$ q+ @8 [. F( Q
Section 2 Diagnosis of Lipoprotein Disorders 45
/ \9 \( R7 _7 Z/ l. n5 LChapter 3 The Importance of Lipid and Lipoprote in Ratios in Interpretetions of Hyperlipidaemia of Pregnancy 47: F$ C- r0 x: E# ~) P% u/ J
D.S. Mshelia and A.A. Kullima
8 }$ t' g* W% @5 R: z9 HChapter 4 A Non-Atherogenic and Atherogenic Lipoprotein Profile in Individuals with Dyslipoproteinemia 73
1 f+ r5 u" r' |' c" t4 V* lStanislav Oravec, Johannes Mikl,
! q7 ?4 K* b, P3 p2 C# aKristina Gruber and Elisabeth Dostal* a1 W; d  f8 {  q0 s! c
Chapter 5 The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk 95
# @3 e! J2 G! O7 a+ l: lGöran Walldius
" f& Z% }  {6 m0 `1 ?Chapter 6 Approaches to Access Biological Data Sources 149# G7 f5 @% k8 A0 x" r4 u0 o
Assia Rharbi, Khadija Amine, Zohra Bakkoury,
  r2 z& a. s* J8 OAfaf Mikou, Anass Kettani andAbdelkader Betari# V( ]- \: S# G6 K9 a  A
VI Contents" ?1 _" D1 C4 o1 `: e; B$ C
Section 3 Hyper- and Dyslipoproteinemias 171! D6 L4 X* j6 K) Q: Q/ w* R$ C
Chapter 7 Lipoproteins Impact Increasing Cardiovascular Mortality 173
+ X3 B; O. y! s2 L4 n( dJelena Umbrasiene, Ruta-Marija Babarskiene and Jone Vencloviene# @7 Y! ?/ P, `5 `6 \7 X
Chapter 8 Lipoproteins and Cardiovascular Diseases 197/ F) s9 R1 r1 B" O. G! j
Adebowale Saba and Olayinka Oridupa
! u. M. i7 j# I# D' F: jChapter 9 Linking the Pathobiology of Hypercholesterolemia with the Neutrophil Mechanotransduction 223
0 `& m- O% L! K6 ^5 d* B8 P1 w4 ^Xiaoyan Zhang and Hainsworth Y. Shin
$ J3 Q7 n  S4 ~% _$ S) `# E) fSection 4 Management of Hyper and Dyslipoproteinemias 253, k3 a$ n% k: {! D" U6 A0 e1 {# u! q
Chapter 10 The Confounding Factor of Apolipoprotein E on Response to Chemotherapy and Hormone Regulation Altering Long-Term Cognition Outcomes 255  q  |0 p. Q1 d' n
Summer F. Acevedo
  y2 w  z/ d) Z) @3 P9 BChapter 11 Anticholesterolemic and Antiatherogenic Effects of Taurine Supplementation is Model Dependent 269
! t% l8 |+ f; j1 G( R4 SKarl-Erik Eilertsen, Rune Larsen, Hanne K. Mæhre, Ida-Johanne Jensen and Edel O. Elvevoll5 \& U8 P3 D/ c- W5 k) b" c
Chapter 12 Endoscopic Treatment of Metabolic Syndrome 2896 ^+ `0 K" u/ M/ V. K- s7 A" K
Eduardo Guimarães Hourneaux de Moura, Ivan Roberto Bonotto
- z% {& H- V' ^4 wOrso, Bruno da Costa Martins and Guilherme Sauniti Lopes7 Z9 u$ S" {3 b+ g1 w) q7 T
Chapter 13 Nutritional Management of Disturbances in Lipoprotein Concentrations 3036 D/ u! D% ^3 y! f! ?! U1 W+ |
Somayeh Hosseinpour-Niazi, Parvin Mirmiran and Fereidoun Azizi* r' n  H; j& k- T6 _: m
Chapter 14 Cyclosporin A-Induced Hyperlipidemia 337! m* Z" Y. K% S/ T" A
Maaike Kockx and Leonard Kritharides
( k) `7 ~, s1 S' {5 k; N/ V& IChapter 15 Lipoproteins and Apolipoproteins of the Ageing Eye 355+ E0 H+ q  ?* J0 |8 h4 ?% i
Edward Loane
/ A3 @7 v2 k) e) Y( {) N, d+ }' ?- zSection 5 Lipid Oxidation and Anti-Oxidants 381
6 a4 C: c+ P/ N# IChapter 16 Pathophysiology of Lipoprotein Oxidation 383( l; x" C, v; n) I2 ~) @
Vikram Jairam, Koji Uchida and Vasanthy Narayanaswami5 ^9 w/ g' J# G
Chapter 17 Oxidized Phospholipids: Introduction and Biological Significance 409  q2 ?0 C) j% Y) h
Mohammad Z. Ashraf and Swati Srivastava
0 I) ?$ Y6 w1 M- Z5 ~" o# `Contents VII+ a1 f5 I& _) X& ?! m2 M$ ^. K. i
Chapter 18 HDL-Associated Paraoxonase 1 Gene Polymorphisms as a Genetic Markers for Wide Spread Diseases 431
& ~& _& M1 _9 }4 j6 |5 ^Ivana Pejin-Grubiša
) s% r# |5 Y' \5 NChapter 19 Antioxidant Complexes and Lipoprotein Metabolism – Experience of Grape Extracts Application Under Metabolic Syndrome and Neurogenic Stress 445- @0 i8 h: O. \- r3 J
Andriy L. Zagayko, Anna B. Kravchenko,5 n$ W8 l, z- |; S& }( F4 e1 |
Mykhaylo V. Voloshchenko and Oxana A. Krasilnikova; }; D' j; T3 j; c! X
Chapter 20 The Anti-Atherogenic Effects of Lycopene 489
4 H# Y& n+ _  B9 e5 a; y6 {Amany M. M. Basuny2 z. A1 R0 g! G& }6 G; [- b" J5 J+ e
Section 6 Animal Models for Lipoprotein Research 507+ E. \% ~( ^: `
Chapter 21 Animal Models as Tools for Translational Research: Focus on Atherosclerosis, Metabolic Syndrome and Type-II Diabetes Mellitus 5099 c! @) R2 n+ @$ l9 {3 ]
Isaac Karimi$ T9 v# G" {5 T5 |: J' Y+ Y
Chapter 22 Genetically Modified Animal Models for Lipoprotein Research 533, |% p3 d  K; F
Masashi Shiomi, Tomonari Koike and Tatsuro Ishida
# y5 w5 k( b5 J" N+ `- `! Q3 sSection 7 Role of Lipoproteins in Neurodegenerative Diseases 561$ `) {0 l" W( b
Chapter 23 Plasma Lipoproteins in Brain Inflammatory and Neurodegenerative Diseases 563
% o& ^6 ]. h  H; l  CArmando Sena, Carlos Capela, Camila Nóbrega,
" S, Y( R  {; {Véronique Férret-Sena, Elisa Campos and Rui Pedrosa$ I5 X$ ]; w2 b7 H( \4 M! F
Chapter 24 Genetics of Ischemic Stroke: Emphasis on Candidate-Gene Association Studies 583( Y2 A) {* P: `1 a
Sanja Stankovic, Milika Asanin and Nada Majkic-Singh2 I+ [& U& t/ K1 X# r. ~5 r- ?. U  [
Chapter 25 Lipoproteins and Apolipoproteins in Alzheimer's Disease 613# \! ^% S4 r+ x2 F% @& S! @$ W; K
Etsuro Matsubara
/ ?: U' V' b0 c- E" ]Section 8 Lipoproteins and Cancer 621
. E+ ^6 T6 ?' z: t, V4 _$ [Chapter 26 Lipoproteins and Cancer 623  w2 F' J# L4 z2 K  D) o7 H
Caryl J. Antalis and Kimberly K. Buhman
6 p# U2 c/ a: c: r$ Y; N1 m5 wChapter 27 Role of Lipoproteins in Carcinogenesis and in Chemoprevention 647$ I5 a: ]! h4 N3 f8 S2 @6 h
Adebowale Bernard Saba and Temitayo Ajibade

s06806

我又回复了  

tuanzi

HOHO~~~~~~  

marysyq

好 好帖 很好帖 确实好帖 少见的好帖  

sky蓝

我等你哟!  

foxok

HOHO~~~~~~  

陈晴

我有家的感觉~~你知道吗  

我心飞翔

应该加分  

foxok

站个位在说  

aakkaa

支持~~